| Literature DB >> 35735668 |
Abel Po-Hao Huang1, Feng-Fang Tsai2, Chien-Chia Chen3, Tzong-Shiun Lee2, Lu-Ting Kuo1.
Abstract
Lumboperitoneal shunt (LPS) implantation is a cerebrospinal fluid diversion therapy for the communicating type of normal-pressure hydrocephalus (NPH); NPH mainly affects older adults. However, endotracheal intubation for mechanical ventilation with muscle relaxant increases perioperative and postoperative risks for this population. Based on knowledge from nonintubated thoracoscopic surgery, which has been widely performed in recent years, we describe a novel application of nonintubated anesthesia for LPS implantation in five patients. Anesthesia without muscle relaxants, with a laryngeal mask in one patient and a high-flow nasal cannula in four patients, was used to maintain spontaneous breathing during the surgery. The mean anesthesia time was 103.8 min, and the mean operative duration was 55.8 min. All patients recovered from anesthesia uneventfully. In our experience, nonintubated LPS surgery appears to be a promising and safe surgical technique for appropriately selected patients with NPH.Entities:
Keywords: hydrocephalus; lumboperitoneal shunt; nonintubated anesthesia
Year: 2022 PMID: 35735668 PMCID: PMC9221739 DOI: 10.3390/clinpract12030049
Source DB: PubMed Journal: Clin Pract ISSN: 2039-7275
Figure 1A patient was anesthetized with a laryngeal mask to maintain spontaneous breathing and was placed in a right decubitus position for lumboperitoneal shunt surgery.
Figure 2A patient was anesthetized with a high-flow nasal cannula to maintain spontaneous breathing and was placed in the right decubitus position for lumboperitoneal shunt surgery.
The baseline characteristics and clinical data in these 5 NPH patients.
| Case No. | Age/Sex | Diagnosis | Underlying Diseases | LVEF | Height, cm | Weight, kg | BMI, kg/m2 | Oxygen Delivery | Anesthesia Time (Min) | Operative Time (Min) | Complications |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 78/M | NPH | Laryngeal | 62% | 157.8 | 52.9 | 21.2 | HFNC | 98 | 48 | None |
| 2 | 87/M | NPH | Stroke, DM, Parkinson | 51.8% | 150 | 49 | 21.8 | HFNC | 123 | 59 | None |
| 3 | 66/M | NPH | MI, HTN, CKD | 66.6% | 168 | 51.9 | 18.4 | HFNC | 109 | 64 | None |
| 4 | 75/F | NPH | C-HIVD | 71.2% | 154 | 43 | 18.1 | HFNC | 94 | 60 | None |
| 5 | 94/F | NPH | Heart failure | 61% | 168 | 51.9 | 18.4 | LMA | 95 | 48 | None |
BMI: body mass index; C-HIVD: cervical herniated intervertebral disc; CKD: chronic kidney disease; DM: diabetes mellitus; HFNC: high-flow nasal cannula; HTN: hypertension; LMA: laryngeal mask; LVEF: left ventricular ejection fraction; MI: myocardial infarction; NPH: normal-pressure hydrocephalus.